Drug development is inherently uncertain, spanning complex scientific processes, multi-phase clinical studies, regulatory review cycles, and interdependent CMC activities. Risk-based project planning provides a proactive, structured approach for anticipating challenges, evaluating their potential impact, and making informed decisions that protect timelines, budgets, and compliance obligations. This webinar introduces participants to the principles, tools, and practical applications of risk-based planning as required by modern regulatory expectations and global standards such as ICH Q9 and ICH Q10.
Charles H. Paul
-
April 10, 2026
- 60 Minutes
-
US$149.00
-
Enroll